After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, DAWN falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Day One Biopharmaceuticals Inc is $1.32B. A total of 2.28 million shares were traded on the day, compared to an average of 1.11M shares.
In the most recent transaction, Blackman Samuel C. sold 30,000 shares of DAWN for 13.31 per share on Dec 10 ’24. After the transaction, the HEAD OF R&D now owns 1,034,015 company shares. In a previous transaction on Nov 18 ’24, Bender Jeremy sold 10,554 shares at 13.21 per share. DAWN shares that CHIEF EXECUTIVE OFFICER owns now total 108,377.
Among the insiders who sold shares, Blackman Samuel C. disposed of 2,206 shares on Nov 18 ’24 at a per-share price of $13.21. This resulted in the HEAD OF R&D holding 1,064,015 shares of DAWN after the transaction. In another insider transaction, Dubow Adam sold 3,165 shares at $13.21 per share on Nov 18 ’24. Company shares held by the GENERAL COUNSEL now total 32,162.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, DAWN has a high of $18.07 and a low of $11.94.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. DAWN’s latest balance sheet shows that the firm has $284.31M in Cash & Short Term Investments as of fiscal 2021. There were $220.00k in debt and $8.66M in liabilities at the time. Its Book Value Per Share was $5.51, while its Total Shareholder’s Equity was $281.15M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DAWN is Buy with a score of 4.70.
